Choroidal neovascularisation in pathological myopia: an update in management. Issue 11 (18th October 2005)

• Record Type: Journal Article
• Authors: Chan, W-M; Ohji, M; Lai, T Y Y; Liu, D T L; Tano, Y; Lam, D S C
• Is Part Of: British journal of ophthalmology. Volume 89:Issue 11(2005)
• Page Start: 1522
• Page End: 1528
• Publication Date: 2005-10-18
• Subjects: AMD, age related macular degeneration -- CNV, choroidal neovascularisation -- FA, fluorescein angiography -- ICG-A, indocyanine green angiography -- LMT, limited macular translocation -- MfERG, multifocal electroretinogram -- OCT, optical coherence tomography -- RPE, retinal pigment epithelium -- VA, visual acuity -- VEGF, vascular endothelial growth factor; myopia -- choroidal neovascularisation -- photodynamic therapy -- surgery -- macular translocation; Ophthalmology -- Periodicals; 617.7
• DOI: 10.1136/bjo.2005.074716
• Languages: English
• ISSNs: 0007-1161

Abstract

Abstract : Choroidal neovascularisation (CNV) secondary to pathological myopia is an important cause of significant visual impairment in young and middle aged adults globally and is particularly prevalent in Asian populations. In the past few years, there have been rapid advancements in the different treatments for myopic CNV. The purpose of this perspective is to give an overview of the natural history of myopic CNV and the various treatment options including laser photocoagulation, photodynamic therapy, submacular surgery, and macular translocation surgery. Future directions in the management of myopic CNV are also discussed.